nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—epiphyseal plate—bone cancer	0.151	0.159	CbGeAlD
Amifostine—ALPPL2—mandible—bone cancer	0.12	0.126	CbGeAlD
Amifostine—ALPPL2—jaw skeleton—bone cancer	0.102	0.107	CbGeAlD
Amifostine—ALPPL2—periosteum—bone cancer	0.0768	0.0808	CbGeAlD
Amifostine—ALPPL2—vertebral column—bone cancer	0.0637	0.0669	CbGeAlD
Amifostine—ALPPL2—skull—bone cancer	0.0632	0.0664	CbGeAlD
Amifostine—ALPPL2—leg—bone cancer	0.0613	0.0644	CbGeAlD
Amifostine—ALPPL2—forelimb—bone cancer	0.0608	0.0639	CbGeAlD
Amifostine—ALPPL2—hindlimb—bone cancer	0.0547	0.0575	CbGeAlD
Amifostine—ALPPL2—cartilage tissue—bone cancer	0.0539	0.0566	CbGeAlD
Amifostine—ALPPL2—arm—bone cancer	0.0522	0.0549	CbGeAlD
Amifostine—ALPPL2—appendage—bone cancer	0.0469	0.0493	CbGeAlD
Amifostine—ENPP1—connective tissue—bone cancer	0.0139	0.0146	CbGeAlD
Amifostine—ALPPL2—connective tissue—bone cancer	0.0134	0.0141	CbGeAlD
Amifostine—ENPP1—tendon—bone cancer	0.00955	0.01	CbGeAlD
Amifostine—ALPPL2—bone marrow—bone cancer	0.00892	0.00937	CbGeAlD
Amifostine—Hiccups—Cisplatin—bone cancer	0.00119	0.0287	CcSEcCtD
Amifostine—Body temperature increased—Carboplatin—bone cancer	0.00114	0.0276	CcSEcCtD
Amifostine—Anaphylactoid reaction—Cisplatin—bone cancer	0.000893	0.0215	CcSEcCtD
Amifostine—Feeling hot—Epirubicin—bone cancer	0.000779	0.0188	CcSEcCtD
Amifostine—Apnoea—Methotrexate—bone cancer	0.00077	0.0186	CcSEcCtD
Amifostine—Rigors—Epirubicin—bone cancer	0.000749	0.0181	CcSEcCtD
Amifostine—Feeling hot—Doxorubicin—bone cancer	0.000721	0.0174	CcSEcCtD
Amifostine—Rigors—Doxorubicin—bone cancer	0.000693	0.0167	CcSEcCtD
Amifostine—Hypocalcaemia—Epirubicin—bone cancer	0.000668	0.0161	CcSEcCtD
Amifostine—Acute coronary syndrome—Cisplatin—bone cancer	0.000656	0.0158	CcSEcCtD
Amifostine—Renal failure—Cisplatin—bone cancer	0.000654	0.0158	CcSEcCtD
Amifostine—Myocardial infarction—Cisplatin—bone cancer	0.000653	0.0157	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—IGF1R—bone cancer	0.000646	0.0925	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—bone cancer	0.000631	0.0903	CbGpPWpGaD
Amifostine—Hypocalcaemia—Doxorubicin—bone cancer	0.000618	0.0149	CcSEcCtD
Amifostine—Hiccups—Epirubicin—bone cancer	0.000611	0.0147	CcSEcCtD
Amifostine—Bradycardia—Cisplatin—bone cancer	0.000608	0.0147	CcSEcCtD
Amifostine—Hiccups—Doxorubicin—bone cancer	0.000566	0.0136	CcSEcCtD
Amifostine—Flushing—Cisplatin—bone cancer	0.000555	0.0134	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—IGF1R—bone cancer	0.00055	0.0787	CbGpPWpGaD
Amifostine—Arrhythmia—Cisplatin—bone cancer	0.000534	0.0129	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—EIF2S1—bone cancer	0.000531	0.076	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—PLAU—bone cancer	0.000527	0.0754	CbGpPWpGaD
Amifostine—Dermatitis exfoliative—Methotrexate—bone cancer	0.000502	0.0121	CcSEcCtD
Amifostine—Anaphylactoid reaction—Methotrexate—bone cancer	0.00049	0.0118	CcSEcCtD
Amifostine—Ill-defined disorder—Cisplatin—bone cancer	0.000483	0.0116	CcSEcCtD
Amifostine—Dermatitis exfoliative—Epirubicin—bone cancer	0.00047	0.0113	CcSEcCtD
Amifostine—Malaise—Cisplatin—bone cancer	0.000469	0.0113	CcSEcCtD
Amifostine—Anaphylactoid reaction—Epirubicin—bone cancer	0.000458	0.0111	CcSEcCtD
Amifostine—Convulsion—Cisplatin—bone cancer	0.000451	0.0109	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—PLAU—bone cancer	0.000448	0.0641	CbGpPWpGaD
Amifostine—Discomfort—Cisplatin—bone cancer	0.000438	0.0106	CcSEcCtD
Amifostine—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000435	0.0105	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000427	0.0103	CcSEcCtD
Amifostine—Anaphylactic shock—Cisplatin—bone cancer	0.000425	0.0102	CcSEcCtD
Amifostine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000424	0.0102	CcSEcCtD
Amifostine—Cardiac arrest—Epirubicin—bone cancer	0.000422	0.0102	CcSEcCtD
Amifostine—Tachycardia—Cisplatin—bone cancer	0.000414	0.01	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—MMP2—bone cancer	0.000405	0.058	CbGpPWpGaD
Amifostine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.0004	0.00964	CcSEcCtD
Amifostine—Hypotension—Cisplatin—bone cancer	0.000397	0.00957	CcSEcCtD
Amifostine—Cardiac arrest—Doxorubicin—bone cancer	0.00039	0.00942	CcSEcCtD
Amifostine—Dyspnoea—Cisplatin—bone cancer	0.000379	0.00913	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00037	0.00892	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000362	0.00874	CcSEcCtD
Amifostine—Renal failure—Methotrexate—bone cancer	0.000359	0.00867	CcSEcCtD
Amifostine—Feeling abnormal—Cisplatin—bone cancer	0.00035	0.00844	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000339	0.00818	CcSEcCtD
Amifostine—Renal failure—Epirubicin—bone cancer	0.000336	0.00811	CcSEcCtD
Amifostine—Body temperature increased—Cisplatin—bone cancer	0.000336	0.0081	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000314	0.00757	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—JUN—bone cancer	0.000313	0.0448	CbGpPWpGaD
Amifostine—Hypersensitivity—Cisplatin—bone cancer	0.000313	0.00755	CcSEcCtD
Amifostine—Bradycardia—Epirubicin—bone cancer	0.000312	0.00754	CcSEcCtD
Amifostine—ALPL—Endochondral Ossification—MMP9—bone cancer	0.000312	0.0447	CbGpPWpGaD
Amifostine—Renal failure—Doxorubicin—bone cancer	0.000311	0.0075	CcSEcCtD
Amifostine—Erythema multiforme—Methotrexate—bone cancer	0.00031	0.00748	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—MMP9—bone cancer	0.000305	0.0436	CbGpPWpGaD
Amifostine—Chills—Methotrexate—bone cancer	0.000294	0.0071	CcSEcCtD
Amifostine—Erythema multiforme—Epirubicin—bone cancer	0.00029	0.007	CcSEcCtD
Amifostine—Bradycardia—Doxorubicin—bone cancer	0.000289	0.00698	CcSEcCtD
Amifostine—Flushing—Epirubicin—bone cancer	0.000285	0.00687	CcSEcCtD
Amifostine—Chills—Epirubicin—bone cancer	0.000275	0.00664	CcSEcCtD
Amifostine—Arrhythmia—Epirubicin—bone cancer	0.000274	0.00662	CcSEcCtD
Amifostine—Vomiting—Cisplatin—bone cancer	0.00027	0.00651	CcSEcCtD
Amifostine—Erythema multiforme—Doxorubicin—bone cancer	0.000269	0.00648	CcSEcCtD
Amifostine—Rash—Cisplatin—bone cancer	0.000268	0.00646	CcSEcCtD
Amifostine—Dermatitis—Cisplatin—bone cancer	0.000267	0.00645	CcSEcCtD
Amifostine—ENPP1—Endochondral Ossification—MMP9—bone cancer	0.000265	0.038	CbGpPWpGaD
Amifostine—Ill-defined disorder—Methotrexate—bone cancer	0.000265	0.00639	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—IGF1R—bone cancer	0.000264	0.0378	CbGpPWpGaD
Amifostine—Flushing—Doxorubicin—bone cancer	0.000264	0.00636	CcSEcCtD
Amifostine—Malaise—Methotrexate—bone cancer	0.000257	0.00621	CcSEcCtD
Amifostine—Chills—Doxorubicin—bone cancer	0.000255	0.00615	CcSEcCtD
Amifostine—Arrhythmia—Doxorubicin—bone cancer	0.000254	0.00612	CcSEcCtD
Amifostine—Nausea—Cisplatin—bone cancer	0.000252	0.00609	CcSEcCtD
Amifostine—Ill-defined disorder—Epirubicin—bone cancer	0.000248	0.00598	CcSEcCtD
Amifostine—Convulsion—Methotrexate—bone cancer	0.000247	0.00597	CcSEcCtD
Amifostine—ALPL—AGE/RAGE pathway—EGFR—bone cancer	0.000246	0.0352	CbGpPWpGaD
Amifostine—Chest pain—Methotrexate—bone cancer	0.000243	0.00586	CcSEcCtD
Amifostine—Malaise—Epirubicin—bone cancer	0.000241	0.00581	CcSEcCtD
Amifostine—Discomfort—Methotrexate—bone cancer	0.00024	0.00579	CcSEcCtD
Amifostine—Syncope—Epirubicin—bone cancer	0.00024	0.00578	CcSEcCtD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	0.000237	0.0339	CbGpPWpGaD
Amifostine—Loss of consciousness—Epirubicin—bone cancer	0.000235	0.00567	CcSEcCtD
Amifostine—Anaphylactic shock—Methotrexate—bone cancer	0.000233	0.00562	CcSEcCtD
Amifostine—Convulsion—Epirubicin—bone cancer	0.000231	0.00559	CcSEcCtD
Amifostine—Hypertension—Epirubicin—bone cancer	0.000231	0.00557	CcSEcCtD
Amifostine—Ill-defined disorder—Doxorubicin—bone cancer	0.000229	0.00553	CcSEcCtD
Amifostine—Chest pain—Epirubicin—bone cancer	0.000227	0.00549	CcSEcCtD
Amifostine—Discomfort—Epirubicin—bone cancer	0.000225	0.00542	CcSEcCtD
Amifostine—Malaise—Doxorubicin—bone cancer	0.000223	0.00538	CcSEcCtD
Amifostine—Syncope—Doxorubicin—bone cancer	0.000222	0.00535	CcSEcCtD
Amifostine—Anaphylactic shock—Epirubicin—bone cancer	0.000218	0.00526	CcSEcCtD
Amifostine—Hypotension—Methotrexate—bone cancer	0.000218	0.00525	CcSEcCtD
Amifostine—Loss of consciousness—Doxorubicin—bone cancer	0.000217	0.00524	CcSEcCtD
Amifostine—Shock—Epirubicin—bone cancer	0.000215	0.00518	CcSEcCtD
Amifostine—Convulsion—Doxorubicin—bone cancer	0.000214	0.00517	CcSEcCtD
Amifostine—Hypertension—Doxorubicin—bone cancer	0.000213	0.00515	CcSEcCtD
Amifostine—Tachycardia—Epirubicin—bone cancer	0.000213	0.00513	CcSEcCtD
Amifostine—Chest pain—Doxorubicin—bone cancer	0.00021	0.00508	CcSEcCtD
Amifostine—Discomfort—Doxorubicin—bone cancer	0.000208	0.00502	CcSEcCtD
Amifostine—Dyspnoea—Methotrexate—bone cancer	0.000208	0.00501	CcSEcCtD
Amifostine—Somnolence—Methotrexate—bone cancer	0.000207	0.005	CcSEcCtD
Amifostine—Hypotension—Epirubicin—bone cancer	0.000204	0.00492	CcSEcCtD
Amifostine—Anaphylactic shock—Doxorubicin—bone cancer	0.000202	0.00487	CcSEcCtD
Amifostine—Shock—Doxorubicin—bone cancer	0.000198	0.00479	CcSEcCtD
Amifostine—Tachycardia—Doxorubicin—bone cancer	0.000197	0.00475	CcSEcCtD
Amifostine—Dyspnoea—Epirubicin—bone cancer	0.000194	0.00469	CcSEcCtD
Amifostine—Somnolence—Epirubicin—bone cancer	0.000194	0.00468	CcSEcCtD
Amifostine—Feeling abnormal—Methotrexate—bone cancer	0.000192	0.00463	CcSEcCtD
Amifostine—Hypotension—Doxorubicin—bone cancer	0.000189	0.00455	CcSEcCtD
Amifostine—ENPP1—Metabolism—NDUFA12—bone cancer	0.000186	0.0266	CbGpPWpGaD
Amifostine—Urticaria—Methotrexate—bone cancer	0.000185	0.00447	CcSEcCtD
Amifostine—Body temperature increased—Methotrexate—bone cancer	0.000184	0.00444	CcSEcCtD
Amifostine—Dyspnoea—Doxorubicin—bone cancer	0.00018	0.00434	CcSEcCtD
Amifostine—Feeling abnormal—Epirubicin—bone cancer	0.00018	0.00434	CcSEcCtD
Amifostine—Somnolence—Doxorubicin—bone cancer	0.000179	0.00433	CcSEcCtD
Amifostine—Urticaria—Epirubicin—bone cancer	0.000173	0.00418	CcSEcCtD
Amifostine—Body temperature increased—Epirubicin—bone cancer	0.000172	0.00416	CcSEcCtD
Amifostine—Hypersensitivity—Methotrexate—bone cancer	0.000172	0.00414	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—JUN—bone cancer	0.000168	0.024	CbGpPWpGaD
Amifostine—Feeling abnormal—Doxorubicin—bone cancer	0.000166	0.00401	CcSEcCtD
Amifostine—Pruritus—Methotrexate—bone cancer	0.000165	0.00398	CcSEcCtD
Amifostine—Hypersensitivity—Epirubicin—bone cancer	0.000161	0.00388	CcSEcCtD
Amifostine—Urticaria—Doxorubicin—bone cancer	0.00016	0.00387	CcSEcCtD
Amifostine—Body temperature increased—Doxorubicin—bone cancer	0.000159	0.00385	CcSEcCtD
Amifostine—Pruritus—Epirubicin—bone cancer	0.000154	0.00372	CcSEcCtD
Amifostine—Dizziness—Methotrexate—bone cancer	0.000154	0.00372	CcSEcCtD
Amifostine—ENPP1—Metabolism—NT5C3A—bone cancer	0.000154	0.022	CbGpPWpGaD
Amifostine—Hypersensitivity—Doxorubicin—bone cancer	0.000149	0.00359	CcSEcCtD
Amifostine—Vomiting—Methotrexate—bone cancer	0.000148	0.00357	CcSEcCtD
Amifostine—Rash—Methotrexate—bone cancer	0.000147	0.00354	CcSEcCtD
Amifostine—Dermatitis—Methotrexate—bone cancer	0.000147	0.00354	CcSEcCtD
Amifostine—Dizziness—Epirubicin—bone cancer	0.000144	0.00348	CcSEcCtD
Amifostine—Pruritus—Doxorubicin—bone cancer	0.000143	0.00344	CcSEcCtD
Amifostine—Vomiting—Epirubicin—bone cancer	0.000139	0.00335	CcSEcCtD
Amifostine—Nausea—Methotrexate—bone cancer	0.000138	0.00334	CcSEcCtD
Amifostine—Rash—Epirubicin—bone cancer	0.000137	0.00332	CcSEcCtD
Amifostine—Dermatitis—Epirubicin—bone cancer	0.000137	0.00331	CcSEcCtD
Amifostine—Dizziness—Doxorubicin—bone cancer	0.000133	0.00322	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—JUN—bone cancer	0.000131	0.0188	CbGpPWpGaD
Amifostine—Nausea—Epirubicin—bone cancer	0.00013	0.00313	CcSEcCtD
Amifostine—Vomiting—Doxorubicin—bone cancer	0.000128	0.0031	CcSEcCtD
Amifostine—Rash—Doxorubicin—bone cancer	0.000127	0.00307	CcSEcCtD
Amifostine—Dermatitis—Doxorubicin—bone cancer	0.000127	0.00307	CcSEcCtD
Amifostine—Nausea—Doxorubicin—bone cancer	0.00012	0.00289	CcSEcCtD
Amifostine—ENPP1—Disease—ENO2—bone cancer	8.05e-05	0.0115	CbGpPWpGaD
Amifostine—ENPP1—Disease—DHFR—bone cancer	7.46e-05	0.0107	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ENO2—bone cancer	6.74e-05	0.00965	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—DHFR—bone cancer	6.25e-05	0.00895	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GNA11—bone cancer	5.84e-05	0.00836	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFBR2—bone cancer	5.41e-05	0.00774	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP3A4—bone cancer	5.3e-05	0.00758	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTP1—bone cancer	4.53e-05	0.00648	CbGpPWpGaD
Amifostine—ENPP1—Disease—KIT—bone cancer	3.69e-05	0.00528	CbGpPWpGaD
Amifostine—ENPP1—Disease—BRAF—bone cancer	3.47e-05	0.00497	CbGpPWpGaD
Amifostine—ENPP1—Disease—MDM2—bone cancer	2.91e-05	0.00416	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTGS2—bone cancer	2.8e-05	0.00401	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTGS2—bone cancer	2.35e-05	0.00336	CbGpPWpGaD
Amifostine—ENPP1—Disease—EGFR—bone cancer	1.99e-05	0.00284	CbGpPWpGaD
